Ten Challenges on Cryptococcus and Cryptococcosis

Mycopathologia

Volumn 173, Issue 5-6, 2012, Pages 303-310

  Del Poeta, Maurizio ^a,b   Casadevall, Arturo ^c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Environment; Host immunity; Infectious particles; Mating; Meningoencephalitis; Systems biology; Virulence

Indexed keywords

ARTICLE; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; MEDICAL RESEARCH; MICROBIOLOGY; PATHOGENICITY; VIRULENCE;

BIOMEDICAL RESEARCH; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRULENCE;

CRYPTOCOCCUS GATTII; FILOBASIDIELLA NEOFORMANS;

EID: 84860595405     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9473-z     Document Type: Article

References (61)

1. Harrison TS. The burden of HIV-associated cryptococcal disease. AIDS. 2009; 23(4): 531-2. doi: 10. 1097/QAD. 0b013e328322ffc300002030-200902200-00013.
2. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009; 23(4): 525-30. doi: 10. 1097/QAD. 0b013e328322ffac.
3. Casadevall A, Perfect JR. Cryptococcus neoformans. Washington, DC: ASM Press; 1998. p. 381-405.
4. Fraser JA, Subaran RL, Nichols CB, Heitman J. Recapitulation of the sexual cycle of the primary fungal pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island, Canada. Eukaryot Cell. 2003; 2(5): 1036-45.
5. Stephen C, Lester S, Black W, Fyfe M, Raverty S. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can Vet J. 2002; 43(10): 792-4.
6. Datta K, Bartlett KH, Baer R, Byrnes E, Galanis E, Heitman J, et al. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis. 2009; 15(8): 1185-91.
7. Datta K, Bartlett KH, Marr KA. Cryptococcus gattii: emergence in Western North America: exploitation of a novel ecological niche. Interdiscip Perspect Infect Dis. 2009; 2009: 176532. doi: 10. 1155/2009/176532.
8. Emergence of Cryptococcus gattii-Pacific Northwest, 2004-2010. MMWR Morb Mortal Wkly Rep. 2010; 59(28): 865-8 (Published online in the American Journal of Transplantation 2011; 11: 1989-1992).
9. Byrnes EJ III, Bartlett KH, Perfect JR, Heitman J. Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect. 2011; 13(1): 895-907.
10. Kronstad JW, Attarian R, Cadieux B, Choi J, D'Souza CA, Griffiths EJ, et al. Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat Rev Microbiol. 2011; 9(3): 193-203. doi: 10. 1038/nrmicro2522.
11. Hilbert D. Mathematical problems. Bull Am Math Soc. 1902; 8: 437-79.
12. Casadevall A, Steenbergen JN, Nosanchuk JD. 'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi-the Cryptococcus neoformans paradigm. Curr Opin Microbiol. 2003; 6(4): 332-7.
13. Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin N Am. 2002; 16(4): 837-74, v-vi.
14. Steenbergen JN, Casadevall A. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect. 2003; 5(7): 667-75.
15. Kidd SE, Bach PJ, Hingston AO, Mak S, Chow Y, MacDougall L, et al. Cryptococcus gattii dispersal mechanisms, British Columbia, Canada. Emerg Infect Dis. 2007; 13(1): 51-7.
16. Marongiu B, Piras A, Porcedda S, Tuveri E, Laconi S, Deidda D, et al. Chemical and biological comparisons on supercritical extracts of Tanacetum cinerariifolium (Trevir) Sch. Bip. with three related species of chrysanthemums of Sardinia (Italy). Nat Prod Res. 2009; 23(2): 190-9. doi: 10. 1080/14786410801946221.
17. Wang H, Ye XY, Ng TB. Purification of chrysancorin, a novel antifungal protein with mitogenic activity from garland chrysanthemum seeds. Biol Chem. 2001; 382(6): 947-51. doi: 10. 1515/BC. 2001. 118.
18. Castro A, Lemos C, Falcao A, Fernandes AS, Glass NL, Videira A. Rotenone enhances the antifungal properties of staurosporine. Eukaryot cell. 2010; 9(6): 906-14. doi: 10. 1128/EC. 00003-10.
19. Gertsch J, Tobler RT, Brun R, Sticher O, Heilmann J. Antifungal, antiprotozoal, cytotoxic and piscicidal properties of Justicidin B and a new arylnaphthalide lignan from Phyllanthus piscatorum. Planta Med. 2003; 69(5): 420-4. doi: 10. 1055/s-2003-39706.
20. Niehaus WG, Flynn T. Regulation of mannitol biosynthesis and degradation by Cryptococcus neoformans. J Bacteriol. 1994; 176(3): 651-5.
21. Florio AR, Ferrari S, De Carolis E, Torelli R, Fadda G, Sanguinetti M, et al. Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A. BMC Microbiol. 2011; 11(1): 97. doi: 10. 1186/1471-2180-11-97.
22. Nosanchuk JD, Shoham S, Fries BC, Shapiro DS, Levitz SM, Casadevall A. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med. 2000; 132(3): 205-8. doi: 200002010-00006.
23. Velagapudi R, Hsueh YP, Geunes-Boyer S, Wright JR, Heitman J. Spores as infectious propagules of Cryptococcus neoformans. Infect Immun. 2009; 77(10): 4345-55. doi: 10. 1128/IAI. 00542-09.
24. Botts MR, Giles SS, Gates MA, Kozel TR, Hull CM. Isolation and characterization of Cryptococcus neoformans spores reveal a critical role for capsule biosynthesis genes in spore biogenesis. Eukaryot cell. 2009; 8(4): 595-605. doi: 10. 1128/EC. 00352-08.
25. Bonacini M, Nussbaum J, Ahluwalia C. Gastrointestinal, hepatic, and pancreatic involvement with Cryptococcus neoformans in AIDS. J Clin Gastroenterol. 1990; 12(3): 295-7.
26. Daly JS, Porter KA, Chong FK, Robillard RJ. Disseminated, nonmeningeal gastrointestinal cryptococcal infection in an HIV-negative patient. Am J Gastroenterol. 1990; 85(10): 1421-4.
27. de Otero J, Flor A, Cortes E, Cuenca A, de Torres I, Capdevilea JA. Cryptococcal gastrointestinal ulcerations in an HIV-positive patient. Enferm Infecc Microbiol Clin. 1994; 12(3): 176-7.
28. Garro S, Bava AJ. Cryptococcus neoformans in the gastric contents of an AIDS patient. Rev Argent Microbiol. 2006; 38(4): 206-8.
29. Hutto JO, Bryan CS, Greene FL, White CJ, Gallin JI. Cryptococcosis of the colon resembling Crohn's disease in a patient with the hyperimmunoglobulinemia E-recurrent infection (Job's) syndrome. Gastroenterology. 1988; 94(3): 808-12.
30. Jacobs DH, Macher AM, Handler R, Bennett JE, Collen MJ, Gallin JI. Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job's) syndrome. Gastroenterology. 1984; 87(1): 201-3.
31. Salkowski CA, Bartizal KF, Balish MJ, Balish E. Colonization and pathogenesis of Cryptococcus neoformans in gnotobiotic mice. Infect Immun. 1987; 55(9): 2000-5.
32. Green JR, Bulmer GS. Gastrointestinal inoculation of Cryptococcus neoformans in mice. Sabouraudia. 1979; 17(3): 233-40.
33. Takos MJ. Experimental cryptococcosis produced by the ingestion of virulent organisms. N Engl J Med. 1956; 254(13): 598-601. doi: 10. 1056/NEJM195603292541303.
34. Franzot SP, Hamdan JS, Currie BP, Casadevall A. Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure. J Clin Microbiol. 1997; 35(9): 2243-51.
35. Litvintseva AP, Thakur R, Vilgalys R, Mitchell TG. Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana. Genetics. 2006; 172(4): 2223-38. doi: 10. 1534/genetics. 105. 046672.
36. Bui T, Lin X, Malik R, Heitman J, Carter D. Isolates of Cryptococcus neoformans from infected animals reveal genetic exchange in unisexual, alpha mating type populations. Eukaryot cell. 2008; 7(10): 1771-80. doi: 10. 1128/EC. 00097-08.
37. Campbell LT, Currie BJ, Krockenberger M, Malik R, Meyer W, Heitman J, et al. Clonality and recombination in genetically differentiated subgroups of Cryptococcus gattii. Eukaryot cell. 2005; 4(8): 1403-9. doi: 10. 1128/EC. 4. 8. 1403-1409. 2005.
38. Campbell LT, Fraser JA, Nichols CB, Dietrich FS, Carter D, Heitman J. Clinical and environmental isolates of Cryptococcus gattii from Australia that retain sexual fecundity. Eukaryot cell. 2005; 4(8): 1410-9. doi: 10. 1128/EC. 4. 8. 1410-1419. 2005.
39. Hiremath SS, Chowdhary A, Kowshik T, Randhawa HS, Sun S, Xu J. Long-distance dispersal and recombination in environmental populations of Cryptococcus neoformans var. grubii from India. Microbiology. 2008; 154(Pt 5): 1513-24. doi: 10. 1099/mic. 0. 2007/015594-0.
40. Kozubowski LJH. Profiling a killer, the development of Cryptococcus neoformans. FEMS Microbiol Rev. 2011 (Accepted Article).
41. Fraser JA, Giles SS, Wenink EC, Geunes-Boyer SG, Wright JR, Diezmann S, et al. Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature. 2005; 437(7063): 1360-4.
42. Subramaniam KS, Datta K, Quintero E, Manix C, Marks MS, Pirofski LA. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J Immunol. 2010; 184(10): 5755-67. doi: 10. 4049/jimmunol. 0901638.
43. Dromer F, Levitz SM. Invasion of Cryptococcus into the central nervous system. In: Heitman J, Kozel TR, Kwon-Chung KJ, Perfect J, Casadevall A, editors. Cryptococcus: from human pathogens to model yeats. Washington, DC: ASM; 2011. p. 465-71.
44. Chang YC, Stins MF, McCaffery MJ, Miller GF, Pare DR, Dam T, et al. Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun. 2004; 72(9): 4985-95.
45. Charlier C, Chretien F, Baudrimont M, Mordelet E, Lortholary O, Dromer F. Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol. 2005; 166(2): 421-32.
46. Olszewski MA, Noverr MC, Chen GH, Toews GB, Cox GM, Perfect JR, et al. Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol. 2004; 164(5): 1761-71.
47. Shi M, Li SS, Zheng C, Jones GJ, Kim KS, Zhou H, et al. Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Investig. 2010; 120(5): 1683-93. doi: 10. 1172/JCI41963.
48. McClelland EE, Bernhardt P, Casadevall A. Estimating the relative contributions of virulence factors for pathogenic microbes. Infect Immun. 2006; 74(3): 1500-4. doi: 10. 1128/IAI. 74. 3. 1500-1504. 2006.
49. Macura N, Zhang T, Casadevall A. Dependence of macrophage phagocytic efficacy on antibody concentration. Infect Immun. 2007; 75(4): 1904-15. doi: 10. 1128/IAI. 01258-06.
50. Garcia J, Sims KJ, Schwacke JH, Del Poeta M. Biochemical systems analysis of signaling pathways to understand fungal pathogenicity. Methods Mol Biol. 2011; 734: 173-200. doi: 10. 1007/978-1-61779-086-7_9.
51. Garcia J, Shea J, Alvarez-Vasquez F, Qureshi A, Luberto C, Voit EO, et al. Mathematical modeling of pathogenicity of Cryptococcus neoformans. Mol Syst Biol. 2008; 4: 183-95.
52. Singh A, Qureshi A, Del Poeta M. Quantitation of cellular components in Cryptococcus neoformans for system biology analysis. Methods Mol Biol. 2011; 734: 317-33. doi: 10. 1007/978-1-61779-086-7_16.
53. Ma H, Croudace JE, Lammas DA, May RC. Expulsion of live pathogenic yeast by macrophages. Curr Biol. 2006; 16(21): 2156-60.
54. Alvarez M, Casadevall A. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr Biol. 2006; 16(21): 2161-5.
55. Bergman A, Casadevall A. Mammalian endothermy optimally restricts fungi and metabolic costs. MBio. 2010; 1(5). doi: 10. 1128/mBio. 00212-10.
56. Breakthrough in plant-fungi interaction. Massey University, New Zealand. 2010. http://www. massey. ac. nz/massey/about-massey/news/article. cfm?mnarticle=breakthrough-in-plant-fungi-relationship-07-07-2010. http://www. massey. ac. nz/massey/about-massey/news/article. cfm?mnarticle=breakthrough-in-plant-fungi-relationship-07-07-2010.
57. Eaton C, Cox M, Ambrose B, Becker M, Hesse U, Schardl C, et al. Disruption of signaling in a fungal-grass symbiosis leads to pathogenesis. Plant Physiol. 2010. doi: 10. 1104/pp. 110. 158451.
58. Goldman DL, Huffnagle GB. Potential contribution of fungal infection and colonization to the development of allergy. Med Mycol. 2009; 47(5): 445-56. doi: 10. 1080/13693780802641904.
59. Sorrell TC, Chen SC-A, Phillips P, Marr KA. Clinical perspective on Cryptococcus neoformans and Cryptococcus gattii: implications for diagnosis and management. In: Heitman J, Kozel TR, Kwon-Chung KJ, Perfect J, Casadevall A, editors. Cryptococcus: from human pathogen to model yeast. Washington, DC: ASM; 2011. p. 595-606.
60. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010; 50(3): 291-322. doi: 10. 1086/649858.
61. Desnos-Ollivier M, Patel S, Spaulding AR, Charlier C, Garcia-Hermoso D, Nielsen K, et al. Mixed infections and In Vivo evolution in the human fungal pathogen Cryptococcus neoformans. MBio. 2010; 1(1). doi: 10. 1128/mBio. 00091-10.